We are live on
!
Find out more
Ginkgo Bioworks
DNA
DNA
180 hedge funds and large institutions have $270M invested in Ginkgo Bioworks in 2025 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 51 increasing their positions, 40 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
245% more call options, than puts
Call options by funds: $7.06M | Put options by funds: $2.05M
30% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 27
28% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 40
4% more funds holding
Funds holding: 173 → 180 (+7)
2.95% more ownership
Funds ownership: 64.08% → 67.03% (+2.9%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
38% less capital invested
Capital invested by funds: $437M → $270M (-$167M)
Holders
180
Holders Change
+7
Holders Change %
+4.05%
% of All Funds
2.19%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
35
Increased
51
Reduced
40
Closed
27
Calls
$7.06M
Puts
$2.05M
Net Calls
+$5.01M
Net Calls Change
-$13M
Top Buyers
| 1 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
+$5.83M |
| 2 |
Morgan Stanley
New York
|
+$4.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.53M |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.86M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$2.77M |
